Drugs.com - New Drug Approvals

FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin

BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved...

May 12, 2025 - 10:14
 0
BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved...
Read More

Tags:

Previous Article

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment ...

Next Article

Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Inje...

Related Posts

FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia

FDA Approves Mezofy (aripiprazole) Oral Film for the Tr...

May 12, 2025  0

FDA Approves HemiClor (chlorthalidone) for the Treatment of Hypertension

FDA Approves HemiClor (chlorthalidone) for the Treatmen...

May 18, 2025  0

FDA Approves Conexxence (denosumab-bnht), a Biosimilar ...

May 12, 2025  0